---
layout: post
title: "达安基因业绩快报：2021年度净利润同比增长46.67%"
date: 2022-02-25 17:36:49 +0800
categories: shanghaizhengquanbao·zhongguozhengquanwang
tags: 上海证券报·中国证券网新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/0.002030" data-code="002030|0|2" data-code2="002030|0|6|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=0.002030&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 002030_0" data-code="K 002030|0|2" data-code2="K 002030|0|6|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>达安基因披露业绩快报。公司2021年实现营业总收入7,633,579,395.86元，同比增长42.92%；实现归属于上市公司股东的净利润3,592,074,736.23元，同比增长46.67%；基本每股收益2.5595元。<br /></p><p class="em_media">（文章来源：上海证券报·中国证券网）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202202252289699852>

[返回上海证券报·中国证券网新闻](//finews.withounder.com/category/shanghaizhengquanbao·zhongguozhengquanwang.html)｜[返回首页](//finews.withounder.com/)